Rapt Therapeutics - 53 Year Dividend History | RAPT
Historical dividend payout and yield for Rapt Therapeutics (RAPT) since 1971. The current TTM dividend payout for Rapt Therapeutics (RAPT) as of December 20, 2024 is $0.00. The current dividend yield for Rapt Therapeutics as of December 20, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.032B |
$0.002B |
|
RAPT Therapeutics Inc. is a clinical stage immunology-based biopharmaceutical company. It focuses on discovering, developing and commercializing oral small molecule therapies for oncology and inflammatory diseases. The company's drug candidate consists of FLX475 for the treatment of tumors and RPT193, a CCR4 antagonist for allergic inflammatory disease. RAPT Therapeutics Inc. is based in San Francisco, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
